Publication:
Pericytes for use as a medicament

Thumbnail Image
Files
906 768 Publication (terapia celular).pdf(2.32 MB)
Date
2023-06-28
relationships.isAuthorOfPublication
Profile Picture
Person
Profile Picture
Person
Profile Picture
Person
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Valdor Alonso, Rut ; García Bernal, David ; Moraleda Jiménez, José María ; Martínez Pérez, Salvador
item.page.secondaryauthor
item.page.director
Publisher
publication.page.editor
publication.page.department
Bioquímica y Biología Molecular B e Inmunología
DOI
item.page.type
info:eu-repo/semantics/patent
Description
Abstract
The present invention refers to a substantially pure population of pericytes, or cell suspension comprising pericytes, wherein the pericytes are at least 80% of the total cell population or suspension, characterized in that CMA is inhibited, for example by inhibiting the expression or deleting the gene LAMP2A. In a preferred embodiment, said population or suspension of pericytes is used as a medicament, for instance in the treatment of cancer, preferably glioblastoma
publication.page.subject
Citation
URI
http://hdl.handle.net/10201/195089
item.page.embargo
Collections
Patentes
Ir a Estadísticas